Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Index of Poster Presenters cont’d<br />
17P27<br />
F8 Haplotype and Recomb<strong>in</strong>ant Product Use <strong>in</strong> the<br />
Hemophilia Inhibitor Genetics Study (HIGS)<br />
Schwarz J1 , Donfield S1 , W<strong>in</strong>kler C2 , B<strong>in</strong>ns-Roemer E2 ,<br />
Berntorp E3 , Astermark J3 and the HIGS Study Group<br />
1 2 Rho, Inc., Chapel Hill, NC, U.S.A., National Cancer Institute<br />
at Frederick, Frederick, MD, U.S.A., 3Malmö University<br />
Hospital, Malmö, Sweden<br />
17P28<br />
Functional-Molecular Magnetic Resonance Imag<strong>in</strong>g for Early<br />
Characterization of Hemophilic Arthropathy <strong>in</strong> a Rabbit<br />
Model<br />
Doria A1 , Amirabadi A1 , Miller E2 , Cheng H1 , Zhong A1 ,<br />
Sussman M3 1The Hospital For Sick Children, Toronto, ON, Canada<br />
2Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada,<br />
3Toronto General Hospital, Toronto, ON, Canada<br />
17P29<br />
New INSIGHT <strong>in</strong> Inhibitor Development <strong>in</strong> Mild/Moderate<br />
Hemophilia A: Inhibitors Arise After More Exposure Days<br />
than <strong>in</strong> Severe Disease<br />
Eckhardt C, Peters M, Fijnvandraat K<br />
Paediatric Haematology, Emma Children’s Hospital,<br />
Amsterdam, the Netherlands<br />
17P30<br />
Surgery as a Risk Factor for Inhibitor Development <strong>in</strong><br />
Hemophilia A: A Systematic Review<br />
Eckhardt C1, 2 , Van der Bom J3 , Van der Naald M2 , Peters M1 ,<br />
Kamphuisen P2 , Fijnvandraat K1 1Paediatric Haematology, Emma Children’s Hospital,<br />
Amsterdam, the Netherlands, 2Vascular Medic<strong>in</strong>e, Academic<br />
Medical Center, Amsterdam, the Netherlands, 3Cl<strong>in</strong>ical Epidemiology, Leiden University Medical Center, Leiden, the<br />
Netherlands<br />
17P31<br />
A Sensitive and Specific Chromogenic Assay for the<br />
Detection of “Functional FVIII Inhibitors”<br />
Ghosh K, P<strong>in</strong>to P, Kulkarni B, Shetty S<br />
Department of Haemostasis and Thrombosis, National<br />
Institute of Immunohaematology (ICMR), KEM Hospital,<br />
Mumbai, India<br />
17P32<br />
Surgery and Transfusions Are Associated With Higher<br />
Inhibitor Incidence <strong>in</strong> 104 PUPS With Severe Hemophilia A<br />
Goudemand J1 , Bridey F2 , Rothschild C3 , Gruel Y4 , V<strong>in</strong>ciguerra<br />
C5 , Grou<strong>in</strong> J6 , Négrier C7 , Calvez T8 , Tellier Z2 1 2 3 Haemophilia Centres of Lille, LFB, Les Ulis, Paris-Necker,<br />
4 5 6 Tours, Haematology Department, Lyon-Herriot, University<br />
of Rouen, 7Lyon-Herriot, 8Inserm & UPMC UMR-S 943, Paris,<br />
France<br />
17P33<br />
Determ<strong>in</strong>ants of High Titer Inhibitor Development: The Canal<br />
Study<br />
Gouw S 1,2 , Mancuso E 3 , Santagost<strong>in</strong>o E 3 , van den Berg M 2, 4 ,<br />
van der Bom J 5<br />
1 Department of Paediatrics, Wilhelm<strong>in</strong>a Children’s Hospital,<br />
UMCU, the Netherlands, 2 Department of Laboratory<br />
Medic<strong>in</strong>e, University Medical Center Utrecht, Utrecht, the<br />
Netherlands, 3 Angelo Bianchi Bonomi Haemophilia and<br />
Thrombosis Centre, Department of Internal Medic<strong>in</strong>e and<br />
Dermatology, IRCCS Maggiore Hospital, Mangiagalli and<br />
Reg<strong>in</strong>a Elena Foundation and University of Milan, Milan, Italy,<br />
4 Meander Medical Center, Amersfoort, the Netherlands,<br />
5 Department of Cl<strong>in</strong>ical Epidemiology, Leiden University<br />
Medical Center, the Netherlands<br />
17P34<br />
Sequential Comb<strong>in</strong>ed Bypass<strong>in</strong>g Therapy is Safe and Effective<br />
<strong>in</strong> the Treatment of Unresponsive Bleed<strong>in</strong>g <strong>in</strong> Adults and<br />
Children with Hemophilia and Inhibitors<br />
Gr<strong>in</strong>geri A1 , Fisher K2 , Karafoulidou A3 , Klamroth R4 , López-<br />
Fernández M5 , Mancuso E1 1Angelo Bianchi Bonomi Haemophilia and Thrombosis<br />
Centre, Fondazione Ospedale Maggiore Policl<strong>in</strong>ico and<br />
University of Milan, Milan, Italy, 2Van Creveldkl<strong>in</strong>iek,<br />
Department of Hematology, University Medical Center<br />
Utrecht, Utrecht, the Netherlands, 32nd Blood Transfusion<br />
Center and Hemophilia Center, Laikon General Hospital,<br />
Athens, Greece, 4Hämophilie-Zentrum, Am Vivantes-Kl<strong>in</strong>ikum<br />
<strong>in</strong> Friedrichsha<strong>in</strong> Zentrum für Gefäßmediz<strong>in</strong> Berl<strong>in</strong>, Germany,<br />
5Servicio de Hematología y Hemoterapia, Complexo<br />
Hospitalario Universitario A Coruña, A Coruña, Spa<strong>in</strong><br />
17P35<br />
A Comparison of Prescribed and Actual Recomb<strong>in</strong>ant Factor<br />
VIIa (rFVIIa) Dos<strong>in</strong>g <strong>in</strong> Pediatric Versus Adult Patients with<br />
Congenital Hemophilia With Inhibitors (CHwI): Analysis of<br />
the Dos<strong>in</strong>g Observational Study <strong>in</strong> Hemophilia (DOSE)<br />
Gruppo R1 , Kessler C2 , Neufeld E3 , Shapiro A4 , Cooper D5 ,<br />
Carr, Jr. M5 1C<strong>in</strong>c<strong>in</strong>nati Children’s Hospital Medical Center, C<strong>in</strong>c<strong>in</strong>nati,<br />
OH, U.S.A., 2Georgetown University Medical Center,<br />
Wash<strong>in</strong>gton, DC, U.S.A. 3Childrens Hospital of Boston, MA,<br />
U.S.A., 4Indiana Hemophilia and Thrombosis Center,<br />
Indianapolis, IN, U.S.A. 5Novo Nordisk Inc., Pr<strong>in</strong>cetown, NJ,<br />
U.S.A.<br />
17P36<br />
International Prospective Randomised Immune Tolerance<br />
(ITI) Study: Interim Analysis of Therapeutic Efficacy and Safety<br />
Hay C1 , Goldberg I2 , Foulkes M1 , DiMichele D2 1 2 University Dept of Haematology, Manchester, U.K., Weill<br />
Medical College of Cornell University, U.S.A.<br />
69<br />
Posters, Tuesday and Wednesday